Follicular Lymphoma: Symptoms, Risk Factors, and Treatment Options

Introduction

Follicular lymphoma is a type of non-Hodgkin lymphoma (NHL), a cancer that originates in the lymphatic system, which is part of the body’s immune defense. First identified in the early 20th century, follicular lymphoma is characterized by the slow growth of abnormal B-cells, a type of white blood cell. It is considered an indolent (slow-growing) form of lymphoma, meaning many patients may live with the disease for years without significant symptoms. However, it can progress over time and may require treatment if it becomes more aggressive.

This article provides a clear, patient-friendly overview of follicular lymphoma, including its risk factors, symptoms, diagnostic tests, treatments, and ways to manage symptoms at home. By understanding these aspects, patients can feel more empowered to make informed decisions about their health and treatment options.

What is Follicular Lymphoma?

Follicular lymphoma is a slow-growing cancer of the lymphatic system. This article covers its risk factors, symptoms, diagnostic tests, medications, procedures, and home-based strategies to help manage symptoms.

Description of Follicular Lymphoma

Follicular lymphoma is a type of non-Hodgkin lymphoma that primarily affects B-cells, a type of white blood cell responsible for producing antibodies to fight infections. In follicular lymphoma, these B-cells become abnormal and accumulate in lymph nodes, forming clusters or “follicles.” Over time, these abnormal cells can spread to other parts of the body, including the bone marrow, spleen, and other organs.

The progression of follicular lymphoma is typically slow, and many patients may not experience symptoms for years. However, in some cases, the disease can transform into a more aggressive form, requiring more intensive treatment. Often, the disease is diagnosed at an advanced stage because it grows slowly and may not cause noticeable symptoms early on.

According to the American Cancer Society, follicular lymphoma accounts for about 20% of all non-Hodgkin lymphomas in the United States. It is most commonly diagnosed in people over 60 and is slightly more common in women than men. While follicular lymphoma is generally treatable, it is not usually curable, and patients may require ongoing monitoring and treatment to manage the disease over time.

Risk Factors for Developing Follicular Lymphoma

Lifestyle Risk Factors

While the exact cause of follicular lymphoma is not fully understood, certain lifestyle factors may increase the risk of developing the disease. For example, exposure to chemicals like pesticides and herbicides has been linked to a higher risk of non-Hodgkin lymphoma, including follicular lymphoma. Additionally, people with weakened immune systems due to HIV/AIDS or those taking immunosuppressive medications after an organ transplant may be at greater risk.

Smoking and excessive alcohol consumption have also been associated with a higher risk of developing various cancers, including lymphomas. Maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding tobacco and excessive alcohol, may help reduce the risk of developing follicular lymphoma, although these factors alone are not definitive causes of the disease.

Medical Risk Factors

Certain medical conditions and treatments can increase the risk of developing follicular lymphoma. For example, people with autoimmune diseases like rheumatoid arthritis or lupus may have a higher risk of developing lymphoma. Additionally, individuals who have undergone radiation therapy or chemotherapy for other cancers may be at increased risk of developing secondary cancers, including follicular lymphoma.

Chronic infections, such as hepatitis C or Helicobacter pylori (a bacterium that causes stomach ulcers), have also been linked to an increased risk of lymphoma. These infections can cause long-term inflammation, which may contribute to the development of abnormal B-cells in the lymphatic system.

Genetic and Age-Related Risk Factors

Age is one of the most significant risk factors for follicular lymphoma. The disease is most commonly diagnosed in people over 60, and the risk increases with age. While follicular lymphoma can occur in younger individuals, it is much less common in people under 40.

There is also evidence suggesting that genetic factors may play a role in the development of follicular lymphoma. Some studies have shown that people with a family history of lymphoma or other blood cancers may be at a higher risk of developing the disease. However, the genetic basis of follicular lymphoma is not fully understood, and more research is needed to determine the specific genes involved.

In summary, while lifestyle, medical, and genetic factors can all contribute to the risk of developing follicular lymphoma, having one or more of these risk factors does not guarantee that a person will develop the disease. Likewise, some people with no known risk factors may still develop follicular lymphoma.

Common Symptoms of Follicular Lymphoma

Fatigue

Fatigue is a common symptom in patients with follicular lymphoma, occurring in approximately 50-70% of cases. This fatigue is often due to the body’s immune response to the cancer, which can cause systemic inflammation and the release of cytokines—proteins that can make you feel tired. Additionally, the cancer can disrupt normal blood cell production, leading to anemia, which further contributes to exhaustion. Fatigue may worsen as the disease progresses, especially if the lymphoma spreads to the bone marrow, where blood cells are produced. Patients often describe this fatigue as persistent and unrelieved by rest.

Swollen Lymph Nodes

Swollen lymph nodes, or lymphadenopathy, are one of the hallmark signs of follicular lymphoma, occurring in about 80-90% of patients. Lymph nodes become enlarged as lymphoma cells accumulate within them. These swollen nodes are typically painless and may be found in the neck, armpits, or groin. In some cases, the swelling can be so subtle that it goes unnoticed until a medical professional detects it during an examination. Swollen lymph nodes are often the first sign of the disease and may fluctuate in size over time, especially in the early stages.

Night Sweats

Night sweats affect around 30-40% of follicular lymphoma patients. These are episodes of excessive sweating during sleep that can drench clothing and bedding. Night sweats are often associated with fever and are thought to be caused by the body’s immune response to the lymphoma. The immune system releases chemicals like cytokines in an attempt to fight the cancer, which can disrupt the body’s temperature regulation. Night sweats are more common in advanced stages of the disease and may be accompanied by other systemic symptoms like fever and weight loss.

Fever

Fever occurs in about 20-30% of patients with follicular lymphoma. It is often a low-grade fever that comes and goes, but in some cases, it can be more persistent. The fever is usually a result of the body’s immune response to the lymphoma cells. As the immune system tries to fight the cancer, it releases substances that can raise body temperature. Fever is more common in advanced stages of the disease and is often grouped with other symptoms like night sweats and weight loss, collectively known as “B symptoms,” which can indicate a more aggressive form of the disease.

Weight Loss

Unintentional weight loss occurs in about 20-30% of follicular lymphoma patients. This weight loss is typically defined as losing more than 10% of your body weight over six months without trying. The weight loss is often due to the body’s increased energy expenditure as it fights the lymphoma. Additionally, the cancer can affect your appetite and metabolism, leading to a reduction in food intake. Like fever and night sweats, significant weight loss is considered a “B symptom” and may indicate a more advanced stage of the disease.

Itching

Itching, or pruritus, affects about 10-20% of patients with follicular lymphoma. The exact cause of itching in lymphoma is not fully understood, but it is believed to be related to the release of cytokines and other inflammatory substances by the immune system. These chemicals can irritate the skin and cause itching. In some cases, itching may be localized to areas where lymph nodes are swollen, but it can also be widespread. Itching can be particularly bothersome and may interfere with sleep and daily activities.

Abdominal Pain

Abdominal pain occurs in about 10-20% of patients with follicular lymphoma. This pain is usually due to the enlargement of lymph nodes in the abdomen or the spleen, which can press on surrounding organs. The pain may be dull and persistent or sharp and intermittent, depending on the location and size of the swollen lymph nodes. In some cases, the lymphoma may also cause bowel obstruction, leading to more severe abdominal pain and digestive issues. Abdominal pain is more common in advanced stages of the disease.

Chest Pain

Chest pain is a less common symptom, affecting about 5-10% of follicular lymphoma patients. It can occur when enlarged lymph nodes in the chest press on the lungs or heart, causing discomfort or difficulty breathing. In some cases, the lymphoma may also cause fluid to accumulate around the lungs (pleural effusion), which can lead to chest pain and shortness of breath. Chest pain is more likely to occur in advanced stages of the disease when the lymphoma has spread to the chest area.

Anemia

Anemia, or a low red blood cell count, affects about 30-40% of patients with follicular lymphoma. Anemia occurs when the lymphoma spreads to the bone marrow, where blood cells are produced, and disrupts the production of red blood cells. This can lead to symptoms like fatigue, weakness, and shortness of breath. Anemia may also be caused by chronic inflammation or blood loss due to the lymphoma. It is more common in advanced stages of the disease and can significantly impact a patient’s quality of life.

Recurrent Infections

Recurrent infections occur in about 20-30% of patients with follicular lymphoma. The lymphoma can weaken the immune system by affecting the production and function of white blood cells, which are responsible for fighting infections. As a result, patients may experience frequent infections, such as respiratory infections, urinary tract infections, or skin infections. Recurrent infections are more common in advanced stages of the disease or in patients who have undergone treatment, such as chemotherapy, which can further suppress the immune system.

Treatment Options for Follicular Lymphoma

Medications for Follicular Lymphoma

Rituximab

Definition: Rituximab is a monoclonal antibody that targets the CD20 protein found on B-cells, including those affected by follicular lymphoma. It works by helping the immune system identify and destroy these cancerous cells.

How and When It’s Used: Rituximab is often a first-line treatment for follicular lymphoma, either used alone or in combination with chemotherapy. It is administered intravenously and can be effective in both early and advanced stages of the disease. Additionally, it is used for maintenance therapy to help prolong remission.

Expected Outcomes: Rituximab can significantly reduce the number of cancerous B-cells, leading to remission in many patients. Responses are typically seen within weeks, and remission may last for several years.

Bendamustine

Definition: Bendamustine is a chemotherapy drug that damages the DNA of cancer cells, preventing them from growing and dividing.

How and When It’s Used: Bendamustine is often combined with Rituximab for treating advanced follicular lymphoma. It is administered intravenously and is frequently used when other treatments have failed or when the disease has relapsed.

Expected Outcomes: Bendamustine can induce remission, with responses typically seen within a few months. It is effective in slowing disease progression and extending survival.

CHOP

Definition: CHOP is a combination chemotherapy regimen that includes Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone. This regimen is designed to target and kill rapidly dividing cancer cells.

How and When It’s Used: CHOP is often used in more aggressive or advanced cases of follicular lymphoma. It is administered in cycles, typically every three weeks, and is frequently combined with Rituximab (R-CHOP).

Expected Outcomes: CHOP, especially when combined with Rituximab, can lead to remission. Responses are usually seen within a few months, providing long-term disease control.

Obinutuzumab

Definition: Obinutuzumab is a monoclonal antibody that also targets the CD20 protein on B-cells, similar to Rituximab, but with a slightly different mechanism of action.

How and When It’s Used: Obinutuzumab is used in combination with chemotherapy for patients who have not responded to Rituximab. It is administered intravenously and is often used in relapsed or refractory cases.

Expected Outcomes: Obinutuzumab can induce remission in patients who have not responded to other treatments. Responses are typically seen within a few months, offering long-term disease control.

Ibrutinib

Definition: Ibrutinib is a targeted therapy that inhibits Bruton’s tyrosine kinase (BTK), a protein that helps B-cells survive and grow.

How and When It’s Used: Ibrutinib is used for relapsed or refractory follicular lymphoma in patients who have not responded to other treatments. It is taken orally as a daily pill.

Expected Outcomes: Ibrutinib can slow disease progression and induce remission. Responses are typically seen within a few months, providing long-term disease control.

Lenalidomide

Definition: Lenalidomide is an immunomodulatory drug that enhances the immune system’s ability to fight cancer cells and inhibits the growth of blood vessels that feed tumors.

How and When It’s Used: Lenalidomide is often combined with Rituximab for relapsed or refractory follicular lymphoma. It is taken orally and is typically used when other treatments have not been effective.

Expected Outcomes: Lenalidomide can induce remission and slow disease progression. Responses are usually seen within a few months.

Etoposide

Definition: Etoposide is a chemotherapy drug that inhibits the enzyme topoisomerase, which is necessary for cancer cells to divide and grow.

How and When It’s Used: Etoposide is used in combination with other chemotherapy drugs for advanced or relapsed follicular lymphoma. It can be administered intravenously or orally.

Expected Outcomes: Etoposide can reduce the number of cancer cells and slow disease progression. Responses are typically seen within a few months.

Dexamethasone

Definition: Dexamethasone is a corticosteroid that reduces inflammation and suppresses the immune system, helping to control lymphoma symptoms.

How and When It’s Used: Dexamethasone is often combined with chemotherapy to reduce inflammation and enhance the effectiveness of treatment. It can be taken orally or administered intravenously.

Expected Outcomes: Dexamethasone can alleviate symptoms such as swelling and pain, while also improving the effectiveness of chemotherapy.

Fludarabine

Definition: Fludarabine is a chemotherapy drug that interferes with the DNA of cancer cells, preventing them from growing and dividing.

How and When It’s Used: Fludarabine is used in combination with other chemotherapy drugs for relapsed or refractory follicular lymphoma. It can be administered intravenously or orally.

Expected Outcomes: Fludarabine can reduce the number of cancer cells and slow disease progression. Responses are typically seen within a few months.

Cyclophosphamide

Definition: Cyclophosphamide is a chemotherapy drug that damages the DNA of cancer cells, preventing them from growing and dividing.

How and When It’s Used: Cyclophosphamide is often combined with other chemotherapy drugs, such as in the CHOP regimen, for advanced or aggressive follicular lymphoma. It can be administered intravenously or orally.

Expected Outcomes: Cyclophosphamide can reduce the number of cancer cells and induce remission. Responses are typically seen within a few months.

Improving Follicular Lymphoma and Seeking Medical Help

While medical treatments are essential for managing follicular lymphoma, lifestyle changes and home remedies can also enhance your well-being and support your treatment. Consider the following:

1. Maintaining a healthy diet: A balanced diet rich in fruits, vegetables, and whole grains can support your immune system and overall health.
2. Staying physically active: Regular exercise can boost your energy levels, reduce fatigue, and improve your quality of life.
3. Managing stress: Techniques such as meditation, yoga, and deep breathing exercises can help reduce stress and improve mental well-being.
4. Getting enough rest: Adequate sleep is crucial for healing and recovery during and after treatment.

It’s important to seek medical help if you experience new or worsening symptoms, such as unexplained weight loss, night sweats, or persistent fatigue. Telemedicine offers a convenient way to consult with your healthcare provider from the comfort of your home, ensuring timely care without the need for in-person visits.

Living with Follicular Lymphoma: Tips for Better Quality of Life

Living with follicular lymphoma can be challenging, but there are steps you can take to improve your quality of life:

1. Stay informed: Understanding your condition and treatment options empowers you to make informed decisions about your care.
2. Build a support network: Connecting with family, friends, or support groups can provide emotional support and help you cope with the challenges of living with lymphoma.
3. Follow your treatment plan: Adhering to your prescribed treatments and attending regular follow-up appointments is essential for managing your condition effectively.
4. Communicate with your healthcare team: Keep an open line of communication with your doctors and nurses to address any concerns or side effects you may experience.

Conclusion

Follicular lymphoma is a slow-growing type of non-Hodgkin lymphoma that can be effectively managed with a combination of medications, chemotherapy, and lifestyle changes. Early diagnosis and treatment are key to improving outcomes and maintaining a good quality of life. If you or a loved one has been diagnosed with follicular lymphoma, our telemedicine practice is here to provide the care and support you need. Schedule a consultation with one of our primary care providers today to discuss your treatment options and take the first step toward managing your condition.

James Kingsley

Learn More